You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
戴維醫療(300314.SZ):全資子公司寧波維爾凱迪申報醫療器械註冊獲得受理
格隆匯 08-01 16:01

格隆匯8月1日丨戴維醫療(300314.SZ)公佈,公司全資子公司寧波維爾凱迪醫療器械有限公司於近日取得由浙江省藥品監督管理局頒發的1項《受理通知書》,受理號為:械受20244023549。產品名稱為一次性使用多通道單孔腹腔鏡穿刺器。

一次性使用多通道單孔腹腔鏡穿刺器在傳統的多孔腹腔鏡技術上加以改進,在產品上設計有兩個以上器械通道供手術操作,從而以單個切口替代多個切口完成手術,是一種向更小、更隱蔽創口發展的新型產品。本產品的使用能夠減少手術切口部位,加快患者術後恢復速度,有效降低手術疤痕對美觀的影響,其帶來的社會和經濟效益較為顯著,具有較好的應用前景。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account